ALDX
Aldeyra Therapeutics Inc
Halal Rating :
Last Price
$4.84
Last updated:
Market Cap
-
7D Change
1.36%
1 Year Change
56.47%
Company Overview
Industries
Exchange
Next Earnings Date
Aldeyra Therapeutics is a biotechnology company focused on developing innovative therapies to treat immune-mediated diseases. The company's lead product candidates target reactive aldehyde species (RASP), which are thought to contribute to various diseases. Their pipeline includes treatments for ocular and systemic conditions.
The company is currently in clinical development stage and has not yet commercialized any products. Their most advanced programs include reproxalap for the treatment of dry eye disease and allergic conjunctivitis.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Aldeyra Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.